afrezzajustbreathe.com

Afrezza Review: Diabetics Confirm Its Advantages

Afrezza is a new FDA approved super-rapid meal-time inhaled insulin for diabetes that has been available since early 2015. Afrezza can be used in T1D & T2D

Last seen: February 7th at 5:43am — Visit site